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Abstract 
In this paper we aim to develop a patient centered perspective that puts at the centre of our focus 
patient practices and their appropriation of medical information, prescribed use of drugs and of health-
care technology. Within this frame, we will initially discuss evidence from a qualitative case study on the 
role of community pharmacists in patients dealing with their problems. In line with the 2.0 revolution, 
we then suggest a technological architecture based on patient generated content and their health social 
networking – as many Health 2.0 platforms already do – that focuses on local relation and take into 
account the empirically assessed role of pharmacists and investing them with an interesting local task. 
Future challenges and initial reflections of the proposed approach will be discussed at the end. 
Keywords: Patient-Centered View, Community Pharmacist, Social Networking, Patient Generated 
Content 
1 INTRODUCTION 
This paper reports on work from an interdisciplinary project exploring the design of future 
telecommunications services, networks and applications in several ICT related domains. In this work, we 
will focus on the domain of Health Care (HC). In particular, we aim to develop a patient centered 
perspective which places at the centre of our focus patient practices, understanding and their daily 
dealing with medical information, the prescribed use of drugs and of health-care technology. Rather 
than presuppose patients as necessarily passive actors within the HC system as traditionally understood, 
we assume that many patients might pro-actively build local knowledge in order to deal with the 
practicalities and intricacies of their health problems. They might activate local interactions with more 
or less institutionalised actors, often walking around official channels and may also develop non-
compliant strategies and adjust their treatment to prevent their diseases taking undue control over their 
lives.  
In line with the recent rise of more participatory models that extend some of the Web 2.0 characters to 
different domains (e.g. Health 2.0), we believe that many of the mentioned patients’ activities should be 
supported and their outcomes publicly shared so that different patients can learn from each other. At 
the same time, much attention is needed to prevent the circulation of health mis-information and the 
establishment of unsafe practices. 
In order to probe our assumptions and to envision our approach, we have built a qualitative pilot study 
aimed to assess the role of local community pharmacists in patients’ practices and their appropriation of 
medical information, procedures and technology. Drawing on different bodies of literature, we relied on 
the assumption that, among the many HC professionals, pharmacists might often play a role that 
exceeds the simple dispensing of drugs (see for instance, Wathen et al. 2007; Cocksey et al. 2002; Keely, 
2002; Sleath, 1996; Adamcik et al. 1986). They might have the chance to develop friendly interactions 
with some patients and develop a certain familiarity with their problems. They can be the first contact 
for people experiencing practical troubles and an obligatory passage point for those who have been 
prescribed with a drug. In this sense, community pharmacists become not only precious informants 
regarding patients’ real problems, but also actors that might actually play a relevant role for patients 
dealing with their health. In this work, we investigate the interaction between community pharmacists 
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and patients. We acknowledge the need to support a more bottom up knowledge production in the 
medical domain. By focusing on community pharmacists and their customers, we aim to envision a 
future participatory Health Care model that supports a patient centered perspective. 
This paper is organised as follows: The following section will discuss our research approach which is 
aimed at putting patients’ practices and understanding at the center of our scenarios for future ICT 
services. In this sense, we will initially provide another look at the traditional model that prescribes a 
passive role to the patient. We rethink the notion of compliance by showing how a patient centered 
perspective might extend traditional understanding and make room for the production and circulation 
of new and relevant patient generated knowledge. We next discuss the role of community pharmacists 
in the light of evidence from our qualitative field observations and some of the literature from social 
medicine. A series of specific practices involving an interaction between patients and pharmacists is 
then discussed as instances of moments where relevant practical knowledge and safe practices are 
produced. This series of instances aims to inform a participatory platform that we introduce and 
describe in the second part of this paper. Framed within the 2.0 revolution, we start to envision a 
technological proposition based on patient generated content and networking – as many Health 2.0 
platforms already do – but that takes into account the assessed role of pharmacists and invest them 
with an interesting local task. The architecture of such participatory platform will be described and 
accompanied by a design scenario, envisioning how the solution would work. Future challenges and 
initial reflections of our approach will be then discussed. 
2 A PATIENT CENTERED FUTURE OF HEALTH CARE ICT SERVICES 
In a traditional perspective patients are understood as passive actors who should comply with academic 
biomedicine knowledge in order to deal with their health problems. In this case, the role of technology 
would be that of supporting patients to comply when this is too difficult for them. However, this 
perspective might only tell one part of the story. Although traditional literature extensively focused on 
patient adherence to medication, a small number of sociological and anthropological works privileged 
patients’ point of view, sense-making and active practices (Jones, 1979; Helman, 1981; Morgan and 
Watkins, 1988; Donovan, 1992; Verbeek-Heida, 1993). According to Conrad (1985), for instance, 
autonomous patients will develop their own medication practice, even though it may not coincide with 
the institutionalised health professionals' recommendations. Much of this behavior could be seen as 
non-compliance, but, from the patient's perspective it is not. People adjust their regimens to suit their 
life situation. They may be solving a problem that a particular drug or procedure creates. They may 
choose to avoid the stigma of the condition that their medication represents. They may be lowering the 
dosages to see if their condition has improved. In effect, patients may alter their drug regimens in an 
effort to retain their own control. In his study of people with epilepsy, using a fairly standard definition 
of compliance, 42 percent of respondents would be seen as non-compliant.  
Yet from the patient's perspective the issue is not about complying or not complying. Embedded in the 
context of their own experience, their use of medications can better be seen as a form of “self-
regulation." […] Most people with chronic illnesses spend only a tiny fraction of their lives in the "patient 
role." Compliance assumes that the doctor-patient relationship is pivotal for subsequent action, which 
may not be the case. 
For instance, people with diabetes may have the same goal as their doctor, but their method of 
achieving these goals may include altering their regimes to create – for instance – a balance of caloric 
exercise and insulin. A five minute talk with an experienced patient with diabetes type 1 would confirm 
this quite immediately (see for instance Mol, 2008). Take, for instance, the following extract from an 
interview with a Diabetes Type 1 patient: 
I completely manage my therapy myself.... I do not have any interaction with the GP on this aspect.... I 
do it myself also because you come to realise that the GP cannot follow all your specific problems ... so 
what happens is that you make some sort of mental plans […] Every time, I make a plan depending on 
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where I am, what I am supposed to do and it changes according to the fact that I am at home, in the 
office or not, whether I can prepare my food or just get something from a menu.... For instance, when I 
know we are going to be walking for a long time because we are sightseeing somewhere or we are in the 
countryside, I tend to keep my level of glucose a little higher, so instead of 10 units of insulin before 
lunch, I take only 9 or 8.... If I know I will have a football match to play I will do even fewer units... Of 
course, at the beginning, you give it a try and you see what happens, but without self-measurement and 
the meter you cannot even think of doing these things ... and, more importantly, nobody teaches you this 
... Marco, Diabetes type 1 patient 
While a traditional understanding would depict patients as passive actors in need to comply with 
biomedical knowledge, a patient centered perspective would rather suggest that some patients actually 
actively produce a different kind of local and practical knowledge that might need support too30. 
Compliance is fundamental for many people and it should be supported. However, non-compliance 
should not always be considered a form deviation in need of control and corrections, but rather a 
precious moment where new practical knowledge is produced in real context. Such practical knowledge 
that some patients might produce is different from the one institutionalised actors, such as the GP, can 
provide and could be of great help for those whom experience the same problems and are in need to 
develop their own personal and safe medication practices. According to Marco, you learn this by 
experimenting, self-measuring and looking at other patients who do not simply stick with an academic 
value (which he defines as a fetish or what the GP asks you to do). Assuming the patients can learn from 
one another (not only to comply), the question then becomes: how to sustain the development of a 
patient centered approach that supports appropriation and the production of practical knowledge in 
Health Care without fostering the circulation of mis-information and unsafe practices? 
3 RESEARCH APPROACH AND FOCUS ON COMMUNITY PHARMACISTS 
As we mentioned, we intend to develop a patient-centered understanding of Health Care in order to 
envision future ICT services that privileges patients’ understanding and their proactive role in dealing 
with heath problems. How do people appropriate medical information, construct their own knowledge 
and understanding and reshape – in practice - prescriptive use of drugs and technology? How and when 
is it a dangerous thing to be avoided? How and when is this aspect to be supported, produced and 
reproduced? In order to answer these basic questions, we developed an ethno-methodological 
approach31 based on participant observations of pharmacists/patients interactions and a series of in-
depth interviews with Irish and Italian chronic disease patients and community pharmacists distributed 
in the area of Limerick and Galway (Ireland) and in that of Arezzo (Italy). Observations and interviews 
have been carried out between September 2008 and March 200932. Feedback from pharmacies’ 
customers were also gathered when possible. 
                                              
30
 Macintyre and Oldman wrote: ‘Those who suffer from chronic illnesses, particularly ones that doctors can do little about, 
develop a special kind of knowledge of their condition. This knowledge is of a rather different order from that hold by doctors, 
and from the point of view of the patient, it is subtly superior (1977: 55)’ 
31
 The father figure of this approach, Garfinkel defined ethnomethodology as: “Ethnomethodological studies analyse everyday 
activities as members’ methods for making those same activities visibly-rational-and-reportable-for all- practical-purposes, i.e., 
“accountable,” as organisations of commonplace everyday activities” (Garfinkel, 1967, p. vii). In this sense, our perspective 
aimed to privilege and to focus on patients’ categories, rationalities, accounts and sense-making without falling into an 
automatic reproduction of the biomedical standard understanding of disease. 
32
 Three Italian pharmacists have been interviewed for 60, 65 and 100 minutes respectively. Three Irish pharmacists have been 
interview for 75, 80 and 90 minutes respectively. One Irish pharmacist has preferred not to be recorded.  Four chronic disease 
patients (hypertension and diabetes) were interviewed for 150, 100, 65 and 60 minutes. Some feedbacks from pharmacies’ 
customers were gathered during participant observations in community pharmacies. Reported names are purely fictional. 
Interviews were informal, open and unstructured although a series of general topics were constantly discussed. Interviews with 
pharmacists generally started with a series of questions concerning professional and legal obligations, then compared with a 
series of activities and daily practices that seem to surpass and exceed pharmacist’s formal role. A series of questions regarding 
their relation with GPs and what they found problematic in this relationship also followed along with a series of questions 
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The idea of investigating pharmacists came from the fact that it is very difficult to investigate patients' 
private practices. How they deal with their health conditions on their own is typically inaccessible for the 
researcher unless s/he would enter their houses for extensive periods of time. Community pharmacists 
might instead have privileged access to some patient practices as they probably are one of the most 
intimate HC professionals people might rely on. Specialised literature already has show that some 
people might prefer to consult with the local pharmacist before – or even instead of – going to the GP. 
For example, in discussing the appropriation of medical information of people coming from rural areas, 
Wathen and Harris (2007) reported: 
‘”Doctors are so overworked they don’t have time to have friendly discussions with people.” Another 
said, “Doctors don’t have a lot of time so you have to be very prepared. You have to go in with your 
questions and know exactly what information you’re looking for. It’s almost like you need to know the 
answers before you ask the questions. I find a lot of doctors tend to talk at you instead of with you” 
Our observations, interviews and feedback from customers who use pharmacies’ reaffirm this point and 
produced interesting evidence about the active role of community pharmacists. Their familiarity with 
many patients’ practices, the problems they experience and patients’ appropriation of medical 
information and technology were some of the observed information. Although our interviewed 
pharmacists were located in small urban communities and not rural areas, they all confirmed Wathen 
and Harris' evidence as the next series of extracts from our interviews show: 
‘Lots of people come here first, not only because they have a small problem but also because they do not 
want to go to the GP: it takes time and money. Some people also say: I do not like to be treated like a 
number, I want to be treated like a person…’ Elisabeth, Irish Ph. 
‘…we are probably unique in relation to the other Health Care professionals, you can walk through the 
door and demand information ...you cannot walk to any other HC professional in this way: you have to 
wait for the doctor, you have to wait for you dietician ...we cannot hide from that, we are here all the 
time...’ Ian, Irish Ph. 
What emerges from these extracts support the idea that patients pro-actively build their own health 
practices and understanding by creating their own local social networks of experts and non-experts and 
by relying on a series of resources that might not coincide with the institutional setting where patients 
are supposed to passively adopt prescribed behaviors. Community Pharmacists, in the case we 
witnessed, turned out to play an often-interesting role that surpasses the simple dispensing of drugs and 
that might support the development of a patient-centered approach to future HC services. As Wathen et 
al. (2007) showed by talking of the proactive role of pharmacists:  
‘Like dieticians, pharmacists are familiar with non-compliant patients...the info(r)mediary work of 
pharmacists is directed to information accuracy and patient self-determination rather than compliance.’  
In discussing the increase in pharmaceutical demand, Cooksey et al. (2002) describes this aspect in term 
of Pharmacists' shift to a patient focus: 
“Shifting from a dispensing focus to a patient focus has been particularly challenging in community and 
retail pharmacies. Progress in the past five years has included offering expanded patient counselling, 
immunisations, and medication-dependent disease management for persons with certain chronic 
conditions (such as asthma, diabetes, hypertension, and high cholesterol). […] Surveys [...] have reported 
a wide range of clinical and management functions: tracking adverse drug effects, participating in 
                                                                                                                                                  
concerning their relations with patients. How different patients might appear, what problems they raise and their nature, what 
practical aspects emerge in dealing with medical technology, with emergencies, with self-care and self-medication practices. 
Interview with chronic disease patients revolved around their experience in dealing with their disease and the nature of their 
interaction with institutionalised actors (such as GP, specialists) and different actors (such as patients with the same disease, 
pharmacists, online mentors and so on). Interviewees were constantly invited to provide practical examples and stories instead 
of talking in general terms. 
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programs to reduce medication errors, monitoring patients’ compliance with medication use, and 
conducting medication management programs [pg.29] 
As Keely underlined (2002): '...Pharmacists are moving from prescription provider to pharmaceutical 
care provider...' 33 In a similar study, Sleath (1996) described pharmacists' interaction as participative 
rather than authoritative, especially with elderly people and with patients who were picking up refill 
prescriptions34. 
Interviewed community pharmacists seemed to know quire well a good part of their customers and they 
often feel compelled to act beyond the simple dispensing of drugs. As one pharmacist stressed, “nobody 
is paying me for that, but that is my job”. For instance, interviewed pharmacists receive phone calls from 
patients dealing with their problems, they chat with them and build friendly relationships, and they 
inform, educate and advise patients on their disease and medicines. They support during emergency 
situations, they reassure patients and support them with their medications especially when treatments 
are particularly demanding, they also demonstrate the correct use of certain medical technology among 
other things. On the patient side, many lay people seem to have found it easier to relate with 
community pharmacists. From patients’ feedback gathered in community pharmacies during participant 
observation a series of reasons were particularly recurrent: there are no queues to attend to, no GPs 
bills to pay, a more relaxed and dialogical interaction where patients feel more confident to express 
their doubts and a more accessible language that does not reaffirm the usually asymmetrical 
relationship with more and more busy GPs whose consultations tends to become habitual (as shown in 
Schulz, 1991)35. 
In the next paragraph, we will discuss further and more detailed evidence from our case study. In order 
to inform our patient centered approach and to envision a participative platform for future service, we 
now collect instances of patient/pharmacist interactions and practices that help to better characterise 
the proactive role of patients and the relevance of pharmacists.  
4 FURTHER EVIDENCE FROM THE FIELD 
4.1 Who do I talk to about my health problems? Patients in search of listeners 
As mentioned, interviewed community pharmacists reported many examples of patients who prefer to 
supplement their interaction with the GP with a more relaxed and dialogical interaction with a local 
community pharmacist. 
                                              
33
 In discussing the role of pharmacists in patient care, Schulz (1991) earlier discussed the mentioned shift in terms of 
pharmacist’ risk management (nonjudgmental, not specific, drug centered) and patient-advocacy role which would serve 
patients by providing objective information that would help them to create their own medication practice. 
34
 Literature offers a limitless amount of researches on the extended role of the pharmacist in both natural and experimental 
settings that confirm their pro-active role and their importance as relevant resources for patients. Kodkani et al. (1999) 
discussed the pharmacists’ role in providing travel advice (regarding for instance vaccinations).  Hudmon et al. (2003) analysed 
their role in smoking cessation counseling. Lipton (1995) showed their contribution in rationalising drug therapy while 
Schnipper showed their role in preventing adverse drugs events after hospitalisation (Schnipper, 2006). Delivery influenza 
vaccinations (Steyer et al (2004)), recognition and management of insomnia (Wincor, 1992), promotion of optimal use of 
antimicrobial use (Dickerson et al. 2000), rationalise drug therapy of the aged (Adamcik et al. 1993), supporting self-care 
(McCallian et al, 2002), improving home care for patients with diabetes (Setter, 2000), providing alcohol related advice and 
education (Harris, 1993), explaining illness and medicine to patients (Schommer, 2000; Williford et al. 1995), caring for patients 
with reactive airways disease (Weinberger, 2002) are just a few examples. Moreover, according to Babb (2003) hypertension, 
diabetes, asthma, patient education, smoking cessation or general medication management are just some of the new duties 
that characterised pharmacists. 
35
 This is also quite clear in this extract from an interview reported by Hughes at al. (2003): The pharmacist is bombarded day in 
and day out with people coming in and out. It’s in your face. There are no appointments, you are directly accessible. […] they 
(pharmacy’s costumers) say “I come in to see what you say rather than them going and bothering the GP as it takes up to three 
weeks to get an appointment. Because I can’t get hold of the doctor, I am coming to you.”. Furthermore, Barry et al. (2000) 
draws on the notion of patients’ unvoiced agendas and showed how patients often do not feel comfortable in expressing their 
doubts or preferences to their GP to which they passively attend to. 
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‘…many customers, especially those who are not fully self assured, save their doubts and question for 
me, they feel I know their problems better’ Giulia, Italian Ph. 
‘People often do not tell the doctor if they have problem with their dosage schedule: some just realised 
that when they come in here, but some other do not feel like discussing it with the doctor…and so they 
ask me when they buy their drugs and I revise the dosage schedule with them…’ Claudio, Italian Ph. 
The problem of patients growing uneasiness with GPs' consultations has been addressed in literature. It 
is not only as a result of the increase of medical demand (that put much more pressure on GPs) but also 
as an effect of the establishment of a scientific method in medicine. Borell (1993) stated: ‘As machines 
provided the precision and new tests proliferated, data rather than the patient claimed the physician’s 
attention’. Leder (1992), who also critiqued biomedicine as it treats the body as a machine, has 
addressed a similar point:  
‘At the core of modern medical practice is the Cartesian revelation: the living body can be treated as 
essentially no different from a machine. [...] Insofar as the body is modelled upon a lifeless machine, the 
role of subjective experience in determining one’s health history will tend to be overlooked’  
Also Radley (1994) defended a similar position and explained: 
‘The implication here is that the person must take his or her illness and cope with it in his or her own life, 
removed from the attentions of medical personnel. Where acute illness can be discussed from the 
perspective of the doctor (that is, from the standpoint of biomedicine), the special problems of living with 
chronic illness evade these kinds of explanations’ 
What we learn here is also that – when interacting with their GPs – some patients will probably 
experience an increasing lack of occasions to talk about their feelings and claims regarding the 
practicalities of living with their health conditions. In discussing this problem, Levenstein et al. (1986) 
developed a model of patient centred medicine by introducing the concept of agendas and showed that 
doctors fail to elicit 54% of patient reasons for consulting and 45% of their worries. As a proactive 
reaction, many patients already supplement to this condition by saving their doubts for the interaction 
with the local community pharmacists they know (in addition to - we are inclined to think - people in the 
family, at work or in the consultation waiting room etc.).  
4.2 Get reassured: dealing with difficult treatments and learning from others 
Reassuring is another aspect that emerged quite strongly in the analysis of patients/pharmacist 
interaction that further addresses the need for patients to share their own experiences when dealing 
with difficult treatments. The next series of extracts show this important aspect: 
‘…for many personal points of view you have to interact with people, you do not have to leave them 
alone…take the triple therapy for the users: that is a terrible stuff to do…and you are supposed to take 
that for...what…12 days or so…and so you have to explain that that it is a terrible thing to drink and it 
tastes terrible…but what I am saying is that you reassure them to actually proceed with it, that it is for 
the benefit of their health…[...] you have to be professional and be careful…Ian, Irish Pharmacist 
‘…I always invite people to take their medicine as prescribed. Sometimes prescriptions might be 
complicated and people get confused…if I see that someone is not complying I try to understand what it 
is, if I see a problem I ask them to go back to their doctor and tell him…Claudio, Italian Pharmacist 
'If I see someone is not complying, I ask and try to talk. Are there any problems with the medication? 
Then I can ask them to tell the doctor but definitely I talk with the customer first…Giulia, Italian 
Pharmacist 
This series of extracts further show how patients might benefit from informal interactions, with the 
focus on how to deal with their practical problems. As we can see, pharmacists do not try to necessarily 
achive or impose compliance but rather to provide patients with room to reflect on their problems, to 
get reassured about the difficult aspects of their treatment and to possibly relate with the GP in a more 
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fruitful way. It has been observed also that when possible, pharmacists – who are exposed to this sort of 
discussions with patients - refer to the experiences of other patients they have already interacted with 
and through which they become familiar with specific problems.  
4.3 Medical Technology demonstration: how am I supposed to use this? 
Another interesting aspect that emerges in our case study with all the interviewed community 
pharmacists is that many patients often need support when using medical technology in their domestic 
environments. They need to be instructed (as instruction leaflets are nightmares) and to have a 
demonstration of the correct usage. Moreover, patients seem to especially rely on their pharmacists 
when they experience a technical problem with their medical self-care devices (from blood pressure 
monitors to inhalers) and need support. In both cases, pharmacists turned out to be a reliable central 
actor. The next series of extracts regarding inhalers and nebulisers illustrates this aspect clearly: 
‘usually I show them how it works and I let them try it in the shop. We unpack it together and assemble 
it…it is extremely simple to use but I prefer not to have them taking the box and go home…if they do not 
do it like this they often come back for further explanations…Claudio, Italian Pharmacist 
‘for the Rino-wash for instance I always open the box here in the shop with the patient and I show them 
how to assemble it and use it. A man come in and wanted to return his Rino-wash because – according 
to him – it did not nebulise properly. We have assembled it in here, plugged it in and it was working. 
Giulia, Italian Pharmacist 
An interviewed pharmacist in Galway mentioned a previous experience where she was asked to assess 
the use of inhalers by the local health unit: ‘I was amazed by how many people could not use the inhaler 
properly, for years!!!’ Elisabeth, Irish pharmacist  
This aspect seems to be even more concerning when it comes to more complex technologies such as 
self-testing digital devices and particular elderly users: 
‘One day an old woman did many tests and she brought the device back to the shop because she got too 
many different results. This has also to do with their expectations. People say: it is morning, I have not 
done anything particular, I am home and I feel fine why should I have changes in my blood pressure?’ 
Giulia, Italian Pharmacist 
‘People come in twice and more…they are afraid to make mistakes. When test results vary a lot they 
come back here and ask if they perform the test correctly, if the device work properly, they ask if they 
can double check with my machine here in the shop…’ Claudio, Italian Pharmacist 
This second series of extracts touch upon a very delicate point we have just mentioned in our 
introductory framing. Appropriation of technology has a double face, sometimes it is a good thing - as 
showed by Conrad and confirmed in our interviews with chronic disease patients - but it might also be 
dangerous and detrimental to good treatments and so it can degenerate into bad habits, misuses and 
fallacious understanding of what is going on with a medication36. Again, the informal support of an 
expert such as a pharmacist (or whoever might have developed a certain experience in dealing with 
certain medical technology such as an expert patient) can make a big difference. 
‘a few days ago a woman came in…she was worried about self-testing her blood glucose because she 
was afraid of the needle. “Should I really prick my finger?” She said…and I said: “well, yes but just a very 
little cut, do not worry, let’s do this together…”’ Giulia, Italian Ph. 
                                              
36
 We are not able to quantify how many costumers would appreciate this service. However, we witnesses much appreciation 
in many cases: two elderly women came in to check their blood pressure monitors, and ask for support in measuring their 
pressure; a married couple asked for a demonstration when they bought an aerosol, from their feedback they preferred to have 
a demonstration than to try to rely on instruction leaflets by themselves. 
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5 TOWARD A PARTICIPATIVE MODEL FOR FUTURE PATIENT CENTERED HIS 
Our approach and the evidence from the field have shown many interesting aspects that we intend to 
take into account for the development of future HC services with a particular attention to patients and 
their practices. First of all, we have seen that compliance is not always the standard and that sometimes 
patients proactively develop their own medical practices to let it fit in with their lives. As we have 
introduced in section 1, some patients (and this is particularly evident in chronic disease patients) will 
develop their own medication practices to adjust their treatment to the practicalities of their life and 
gain some control of their disease. Then we have also seen that patients proactively build local social 
networks when they need to supplement the lack of understanding they might experience with GPs. We 
witnessed that while many patients feel in need to talk about their feelings and difficulties, some others 
produce relevant practical knowledge that might be much needed by people who share similar 
problems. Then, we saw that community pharmacists often play a relevant role that exceed the simple 
dispensing of drugs and that they often develop friendly interactions with them. Our initial questions 
about how to support the development of a patient centered approach, how to support good 
appropriation and how to avoid unsafe practices, ask for a participative model which would add to the 
already existing vertical channels based on control and compliance (i.e. traditional channels) and a series 
of new horizontal channels based not on compliance but on appropriation.  In order to address this 
series of issues we have decided to bet on community pharmacists and to envision a patient-centered 
platform that would support future patients to better develop their own local practices and social 
networks, but also to share their experiences with other patients. This series of consideration has 
brought us to look at the Web 2.0 revolution and the emergence of the so-called Health 2.0 as a possible 
solution (and a trend) that, in our opinion, future Health Information Systems cannot ignore. 
5.1 Challenges from the 2.0era: Patient generated content and social networking 
The evolution of the Internet is much studied and its future trends much anticipated. In keeping with 
the terminology of software applications, in particular software upgrades, these have often been 
characterised in terms of version numbers. Thus we have Web 1.0, Web 2.0 and subsequent attempts to 
predict what 3.0 and 4.0 might have to offer. These latter two are speculative and are still highly 
subjective, however we now clearly understand the difference between 1.0 and 2.0 (in retrospect of 
course) and we have some early indication of what the future may hold. Web 1.0 was largely a passive 
experience. Users consumed hypermedia with interaction limited to the most basic transactions. 
Interactions with other Internet users were largely through email and also more anonymously via file 
sharing networks. 
Web 2.0, a term coined at an O'Reilly conference in 2004, heralded a new way of thinking about the 
network. In this vision the user was center stage and User Generated Content (UGC) would drive the 
nature of the network and the uses to which it would be put. This phase has seen the rise of social 
networks (MySpace initially, subsequently overtaken by Facebook and Bebo), weblogs, Instant 
Messaging services and most recently hybrid services epitomised by the current interest in Twitter. 
Mobile connectivity has also been a strong feature with increasingly capable mobile devices connecting 
to the network. The future Internet will see the UGC trend continuing with significantly increased levels 
of interactivity and connectivity. 
As mentioned, within the Health Care domain, this shift has produced a new series of approaches that 
goes under the name of Health 2.0. Even if there is a lack of consensus on its definition, different 
authors agree on the fact that Health 2.0 is based on a participatory model where the pro-activeness of 
patients is taken more seriously than ever before. Staying informed through RSS and podcasts (Giustini, 
2006), support medical education of both GPs or the public (Sandard et al. 2007, Crespo, 2007), 
participating in self-help discussions (Preece, 1998) and managing a particular disease by connecting to 
an on-line community (Ferguson, 2007) are just some of the first instances of the 2.0 chapter of Health 
Information Systems. The web is witnessing the rise of patients’ blogs (e.g. Diabetesmine.com; 
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assertivepatient.com), Health social networks (e.g. dailystrengh.com, patientslikeme.com), health wikis 
(e.g Fluwikie.com; en.wikipedia.org/wiki/health), Health UGC site (e.g. drugs.com), health podcasts (e.g. 
podcasthealth.com) and video sharing (e.g. health channels in youtube.com or ivillage.com, 
iheathtube.com, icyou.com).  
The buzzword for the approach we propose then becomes that of Patient Generated Content, their 
health related social networking and their peer-to-peer interaction. It is worth noting the downside of 
these approaches, as also recently addressed in literature (Hughes, B. et al., 2009), namely, the danger 
of inaccurate information37. What we believe we add to the actual spread of Health 2.0 application 
derives from what we witnessed by looking at community pharmacists anf the relevance of local 
interactions. We have seen how people seek for real interactions where – in a relaxed context – they 
can discuss about their practical problems. Actual Health 2.0 application are always web-based, they 
certainly provide relevant information, probably a more accessible language and even foster 
interactions (mostly asynchronous) but they rarely offer the chance to have face to face interactions 
with people who know about or share similar problems. In this sense, we aim to bet on pharmacists in 
order to add a local dimension to our take of 2.0 Health Information Systems. In the following part of 
this work we will proposed an information system based on these assumptions. 
6 TECHNOLOGICAL PROPOSITION 
The system proposed would embrace and encourage such an approach, with patient-generated content 
and the local formation of social networks facilitated by community pharmacists. Enabling technology 
however is the key to making this a realisation. The core technology used needs to feel familiar and not 
be a barrier to the user. Instant Messaging (IM), is a form of near real time communication between two 
or more users over a network. Simple IM clients provide the basic functionality for users to 
communicate in a one to one fashion. Richer IM clients retain the core text based communication but 
enhance the user experience by integrating audio and video communications, file sharing and context 
sensitive services. 
IM has had a surge of popularity in recent years as the Web 2.0 matured. The paradigm shift to mobile 
computing saw a new wave of innovation. The core concepts and functionality of early communication 
orientated computing, was adapted and brought into this new generation. The result was devices 
became smaller, faster, smarter and ubiquitous. This paradigm shift was aided by the communications 
platform in place. Phones had long switched from analogue to digital but had now advanced to 3G 
speeds. Broadband networks were becoming more main stream allowing for higher bandwidth and 
accessibility for the home user. Public Wi-fi was being established ensuring that an individual could 
remain connected somehow and someway no matter where they went. The information superhighway 
was literally at a person’s fingertip. 
The result of this was the emergence of IM as a primary means of communication for both business and 
social users. The added benefit of using this means of communication to stay in touch is the presence 
and group mechanisms which have evolved with the technology. Contextual information such as 
availability, location and sensor data can be shared seamlessly in a real time manner with online 
“buddies”, the term coined to describe a person’s online contacts. Buddies are logically grouped 
together into user defined “groups”. Common groups would be “friends”, “family” and “work mates”. 
These groups combined, form the users online roster of friends, commonly known as a “buddylist”. A set 
of services can be offered and shared with visibility set to each group within the users’ buddylist. These 
services can be very dynamic, adapting to status, presence and other contextual information in highly 
innovative ways. For instance one modern IM application offers the following: standard one to one chat 
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 In a recent commentary on the Journal of the American Medical Association, Youtube was reviewed as a site of health mis-
information (Dec. 2007), a summary is available here: http://blog.highlighthealth.info/social-networks/youtube-as-a-source-of-
health-misinformation/ 
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service, multi user chat, media chat (voice + video), file transfer, calendar, maps, games, health & 
fitness, news, sports, weather, dating, Q&A, yellow pages, shopping and several other user focused 
services. When one bears in mind that most of these services are to some extent “aware” of aspects of 
the users’ context, and also that these applications are available in mobile and desktop variants, then 
the potential of these platforms is unlike anything we have seen in the past. Of particular interest is 
whether these platforms are based on open standards, and can thus be enhanced in innovative new 
directions. 
The services developed on such systems have a strong reliance on open source standards and protocols, 
enabling highly scalable applications to be built and distributed. The most prominent of these protocols 
is the eXtensible Messaging and Presence Protocol (XMPP) set of standards, also known as Jabber. XMPP 
was formally standardised by the IETF and together with its use of the XML data format it makes the 
protocol the leading choice for near real time communications. Currently over 100 extensions are active 
or in the testing phase expanding the original concept to include such innovative extensions such as 
“User Gaming” [XEP-0196], “User Location” [XEP-0080] and “Location Query” [XEP-0255] to name but a 
few. XMPP would be the underlying technology of choice for driving forward this system38. 
6.1 Explanation of the Architecture: 
  
Figure 1:Architecture proposed 
The architecture highlighted above in figure 1 is what we propose in this paper. A community pharmacy 
would have an enhanced group focused communications server based on XMPP. The communications 
server is running the standard XMPP installation as well as several custom schemas to facilitate dynamic 
group formation, migration, service provision and file sharing. The extensible nature of the system's 
core underlying components would allow for added functionality to be added in the future. This 
                                              
38
 For a more detailed discussion of the architectural structure and its premises see Griffin and de Leastar (2009) and Griffin, 
Foley and de Leastar (2009) 
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functionality could be driven by user trends or the desires of the pharmacist. This provides a future 
proof system with scalability in mind. 
This system would be initially set up by a system developer and handed over to the pharmacist who 
would adopt the role of administrator. The pharmacist registers interested customers as patients of the 
system. Each customer receives an entry on the system, providing them with unique jabber based 
identifications with which to authenticate. This identification would be very similar in style to an email 
address. During the registration process, the pharmacist tags the users profile with key words. These key 
words will be used to dynamically create the groups and populate them with the correct individuals. Key 
words or tags, - provided by the patient- can include an overall classification of the patients ailment 
(such as hypertension, diabetes asthma), the types of medication that the patient is currently prescribed 
(cardio aspirin, salbutamol) and any external devices required by the patient as part of their prescription 
(diabetes pens, blood pressure monitors). Customised tags decided upon by the pharmacist are also 
possible. By associating each patient with such key words, the system can form closely related groups. 
Patients can and will hold simultaneous membership of groups and group membership can be added to 
or indeed revoked if need be. A full log of memberships, both past and present are also recorded for the 
pharmacist. 
A number of benefits to having patients logically divided into groups exist for the core users of the 
system. From the pharmacist’s perspective, custom information and specialized services can be tailored 
at these groups, providing key, relevant and timely information. User generated content can be 
validated by the pharmacist. From the customer’s point of view, they are able to freely interact, share 
information and even meet with other community members who suffer from a similar ailment or simply 
look for contents of interest that have been commentented by a pharmacist. Sharing customised 
services, health tips and obtaining vital peer support would be very important for the interested 
customer.  
Control over data and services would also be limited by group membership. The pharmacist and more 
importantly the patients could create and publish new content (audio, video, services) to the groups. 
The content itself could be tagged with the appropriate group names, thereby making it only visible to 
those it is most relevant to. This would keep data private to an extent and allow for greater 
customisation, as the content would be patient centric and patient driven. 
6.2 User Scenario: an example of system in use 
Having signed up for the service and gone through the registration process and a system walkthrough in 
the pharmacy, a customer, John Doe, receives an information pack from the pharmacist outlining the 
steps for using the system. Included in the pack are all the details required to install the software on his 
home device and an instructional video. After successfully installing the client side software, John logs 
onto the homepage of the system. His homepage shows a number of public and private groups. The 
private groups are groups which the pharmacist has associated with the user during the registration 
process. Diabetes, Insulin and Diabetes Pen are the three groups associated with the user. The public 
groups are special interest topics such as hobbies and sports which enhance the social dimension of the 
system. The user is prompted to enter his home location. Upon doing this, a new group, geographical 
neighbours, appears on his homepage. The system has taken John’s home location and added him as a 
member to the geographical group that corresponds to his home area. Within the group are four 
neighbors of the user who also use the system. Selecting the group, the user is brought to a new page. 
This page has an Instant Messaging chat room but nobody in this group is online. John notices a news 
information widget is also available with community notices posted by the users of the group. Backing 
out and entering the Diabetes group, John notices a lot more activity and content available. Widgets 
linking to other users blogs on the system are advertised. These blogs serve as a place where they can 
record an online journal of their daily battle with their illness. John selects the content area, and within 
here are a number of user generated services and podcasts. A dietary service catches his eye and he 
downloads it to his home area for later use. This service has a 7 day meal list for diabetes patients who 
556 
like to maintain a tough fitness regime. It comes with a disclaimer, “not approved by the pharmacist 
yet”, informing John that the advice given has not been verified and could possibly be misleading. 
John backs out and enters the online chat area. Here a group chat is going on with other users enjoying 
conversations about the weekend’s football action. John introduces himself and receives a number of 
private messages welcoming him to the system. Some users were good enough to send on some links to 
help him get started. Taking the advice of some of the users he goes about and personalises his 
homepage and creates his first blog. A quick navigation to his homepage shows a content rich screen. 
His old homepage was a number of private groups and default public groups. John’s new homepage has 
a cycling group, a rugby group, his geographical group and his original medical groups. Added to this a 
local newsfeed, two users blogs and his dieterary service are available. Before logging off for the evening 
John tries the service creation tool and creates a service for cycling enthusiasts mapping out his favorite 
country cycling track. He is surprised at the ease and usability of the tool. Upon logging in the following 
day, John is quite pleased to see that another user has downloaded the service and sent him a message. 
In his inbox is a 2nd message from the pharmacist informing all users who downloaded the dietary 
service that he has approved the content and advice.  
7 FUTURE CHALLENGES AND CONCLUSION  
Proposing an architecture that deals with service creation, file sharing and instant communication over 
several personal network domains poses several challenges. Synchronisation, ease of use, mishandling 
of information, illegal content, trust and privacy implications are just some of several problems that – 
although considered in the design - would be encountered in a live system. Addressing these problems 
before they become an issue is thus the real goal even if we can conclude little before to assess a real 
system in a real setting. By adopting a popular network architectural style, embracing open source 
protocols and following good programming practice it might be possible to develop a system that has 
long term stability, scalability and security. Further work to be carried out would be a full requirements 
analysis and prototype design of the system in order for a pilot study to be carried out and refined.  
We are looking forward to assessing our architecture in the field, we can anyhow draw some initial 
conclusions to the approach we are proposing and the evidence we are reflecting on. We have initially 
asked ourselves how to support safe appropriation of medical information, procedures and technologies 
without fostering the circulation of mis-information, and unsafe practices. We have seen that a bottom-
up, patient centered approach would ask to look at patients not so much as passive actors who have to 
comply with doctors orders but rather as proactive actors that develop relevant, local and practical 
knowledge on how to deal and live with their disease. We believe that sharing this information is vital in 
a future HC in need to contains endlessly increasing costs. Research on Health Care information systems 
has already showed that the identification of actors and their role should be dynamic, iterative and 
interpretative (Pouloudi, 1998). As Pouloudi and Whitley also showed, actors depend on a specific 
context and time frame (1997), moreover they cannot be viewed in isolation as their position will 
change over time (Mantzana and Themistocleous, 2004). In this sense, we have developed a 
participative model where the role of who is producing relevant knowledge and who is consuming it is 
not prefigured in the system in a fixed way thus allowing for dynamic role and group formation. The only 
exception is community pharmacists, who are put in their position to support patients, pointing them to 
similar ones and supervising their shared contents.  
We believe that this is advancement to actual Health 2.0 models for at least two reasons. The first one is 
that while actual Health 2.0 systems do not have any mechanism that prevent the diffusion of mis-
information and unsafe practices (because content can be freely created), the system we propose 
strongly afford safe content to be shared, with unsafe content flagged for the user. The extra ‘validating’ 
work requested to community pharmacists might be a problem but it can be also marginal with respect 
to the possibilities to further increase their interactions and familiarity with patients and their problems 
and consequently their customer fidelity and revenues. The second contribution of our proposition 
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regards the addition of a local dimension to the actual Health 2.0 platforms, which are solely based on 
remote interactions, and which can rarely allow face-to-face encounters with people with similar health 
problems. Thanks to the facilitating role of pharmacists our platform would also afford patients to meet 
face to face as pharmacists are put in the position to point patients to local people in a similar situation. 
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